A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
about
Pathogenesis and management of Kawasaki diseaseIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for the treatment of Kawasaki disease in childrenKawasaki syndromeAssociated symptoms of kawasaki diseaseInterleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki diseaseAcute Kawasaki disease: not just for kidsIntravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory DermatosesTreatment of Kawasaki disease by different doses of immunoglobulin: a meta analysis of efficacy and safetyKawasaki disease: an updateRe-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapyComparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndromeInflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of feverIncomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximabHigh-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseaseUrinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile IllnessesGenome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease.Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndromeAn infant with γ-globulin-induced hypersensitivity syndrome who developed Evans' syndrome after a second γ-globulin treatment.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europePoint-of-care differentiation of Kawasaki disease from other febrile illnesses.Genetic polymorphisms in Kawasaki disease.Effectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease.Management of Kawasaki disease in the British Isles.A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki diseasePharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki diseaseThe Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.The many faces of Kawasaki syndrome.Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.Spatial and temporal clustering of Kawasaki syndrome cases.When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.In Vitro Validation of Patient-Specific Hemodynamic Simulations in Coronary Aneurysms Caused by Kawasaki Disease.Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.Infliximab treatment for refractory kawasaki disease in korean children.Recognition and management of Kawasaki disease.
P2860
Q22305933-43DE87F0-04B2-4C9F-BD37-8AF98890403EQ24193522-BCE7F254-B719-4BA2-967E-AB792B32ED02Q24202100-0C1D28DE-401D-47BD-8365-7448819F0308Q24247776-4F166D74-44C2-426D-A12C-7A19237A6778Q24550744-3E349217-2A08-49FD-BD85-9694C5E514A5Q24620972-61870690-8B41-4EB8-B350-0AAF93E70C8EQ24633011-01D95CA7-B487-4BEC-B73F-B1B3760A9E97Q24682484-9E7107CF-76B3-44FF-89A8-1F826AF66D7FQ26765226-002D34FA-AFF1-410E-BCA4-057186103048Q27025884-E5421984-585F-4B35-99A6-7E4D93A0AFE4Q28180597-9F31DA46-4C73-4608-8B0D-15CA2A0C8413Q28184382-87098AD9-067C-4614-AB94-D79B85C1D02EQ28194044-0571333F-B6AF-4ECD-8CBD-4D2C3CBCDBB8Q28210872-BE8A0369-83BE-4FED-B352-FF0988434625Q28222748-C35F9D7D-79DE-41F2-9CD7-EB30E88EE995Q28396984-B642BD10-A7B2-4467-A535-3800E4798C11Q28550044-01D276A4-A674-40FF-9089-BA81AF916B72Q29417017-7EF20BE9-44A6-43E7-B6CF-1713F22B4029Q30984727-FAE3CDA4-0202-428B-8E89-AA6205C3A96DQ33265368-BC0042CD-1520-4586-AE4F-4BBC5028577AQ33300097-AEBF8B8D-71D4-4613-9D79-E84D509B8869Q33412457-C0E22A6C-E6B1-4FE5-8AC4-86711C1B1258Q33419638-C9FACF47-9750-4284-A4AF-355FB3C97FACQ33438988-11821D29-0127-4A45-9E95-E33C300C64E7Q33566136-67ACA518-A036-4B0C-9431-352880F0876CQ33685026-EABDBDC0-CCB7-4CE7-8C38-95D5B6BD627AQ33709673-BF48EA78-5AA5-4918-BF37-F902BE65911EQ33718985-D2DF4C8B-9745-41BE-822F-8572EBF7B2B2Q33738998-75C8ADE4-5B32-4858-892D-0BE3BB9B3C25Q33770368-1F1FBC13-AE8D-4EE4-BAF2-6431EC220DDAQ33798966-66732C2C-8DB1-4862-84E8-B936D40C5DEFQ33823464-DCDE29E0-96F3-47F9-9A11-A483942F03B8Q33846481-1B1ACACE-EEA9-4CDA-B547-B7FD94101B65Q33851898-12A1E18D-4E80-489F-862D-31C00019C7ADQ33851902-7604DC45-7633-457C-AC97-5B6322A8EA4AQ33919082-240FF26B-17B5-4A77-9491-017342711549Q33941598-33F371C5-8438-4EE0-8107-7D6CDF799C2EQ34005103-F93F3BD2-F328-4753-BCA2-647E54257207Q34021198-6854C6AC-AA81-428A-83CE-5E42E7F2045FQ34034709-DBFA5F91-FDD3-4A88-9941-345D076FCFF7
P2860
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@ast
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@en
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@nl
type
label
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@ast
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@en
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@nl
prefLabel
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@ast
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@en
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@nl
P2093
P1476
A single intravenous infusion ...... nt of acute Kawasaki syndrome.
@en
P2093
Takahashi M
P304
P356
10.1056/NEJM199106063242305
P407
P577
1991-06-01T00:00:00Z